Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan in patients with digital ulcers associated with systemic sclerosis
jRCT2080222130Phase 3
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Jul 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of bosentan in digital ulcer (DU) and systemic sclerosis (SSc), sponsored by Actelion Pharmaceuticals Ltd.
02
Drugs
bosentan
03
Conditions
digital ulcer (DU)systemic sclerosis (SSc)
Beyond the preview
Go deeper on jRCT2080222130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222130.